Renaissance Technologies - TSCAN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45
-87.8%
17,700
-88.0%
0.00%
-100.0%
Q2 2023$369
+1437.5%
147,462
+1171.2%
0.00%
Q1 2023$24
+50.0%
11,600
+16.0%
0.00%
Q4 2022$16
-100.0%
10,000
-24.8%
0.00%
Q1 2022$37,00013,3000.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$5,254,00020.63%
Deer IX & Co. Ltd. 1,245,505$9,349,0000.96%
DC Investments Management, LLC 35,563$297,0000.55%
Alphabet Inc. 1,077,080$8,983,0000.21%
Monashee Investment Management LLC 100,000$834,0000.15%
RA Capital Management 1,255,317$10,469,0000.14%
HHLR ADVISORS, LTD. 1,282,976$10,700,0000.14%
Tekla Capital Management LLC 200,000$1,668,0000.05%
Baker Brothers Advisors 1,425,000$11,885,0000.05%
CAAS CAPITAL MANAGEMENT LP 75,000$626,0000.01%
View complete list of TSCAN THERAPEUTICS INC shareholders